May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US

19/12/2025 1h 18min

                    May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US

Listen " May the best robot win – Medtronic’s Hugo RAS ready to compete for surgical business in the US "

Episode Synopsis


In this episode of the DeviceTalks Weekly podcast, we give the entire stage to Medtronic’s surgical robotics business in honor of the FDA’s approving the Hugo RAS system for urological procedures.
This episode is sponsored by Confluent Medical Technologies. Visit http://confluentmedical.com/ for more information.
First, MassDevice editor Chris Newmarker asks James Porter, MD, a practicing surgeon and CMO of Medtronic’s surgical business, why he sees as a better alternative for hospitals and surgeons.
Then, Host Tom Salemi visits with Rajit Kamal, the VP of the company’s surgical robotics building to learn what’s next. How will the company take on the massive incumbent, Intuitive.
We’ll also visit with Gayle Grimes, author of MassDevice’s Medtech Market Intelligence Report on surgical robotics. Go here to learn more. https://www.massdevice.com/product/robotic-surgery/
This week’s Newmarker’s Newsmakers are CMR Surgical, Johnson & Johnson MedTech, Olympus, Nephrodite, and Medline.
Go here to listen to Rajit Kamal’s first appearance on the DeviceTalks Weekly podcast: https://www.devicetalks.com/velys-inhance-and-other-reasons-why-depuy-synthes-sees-ortho-opportunities-2021s-top-dtw-episodes/
***
Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters
(00:02:55) - Surgical Report Gayle Grimes(00:10:56) - CMR Surgical wins FDA clearance for next-gen Versius Plus surgical robot in cholecystectomy(00:13:22) - Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA(00:15:03) - Olympus launches second medtech investment fund with $150M(00:16:08) - Continuous dialysis implant wins FDA Breakthrough Device Designation(00:18:33) - Medline prices $7B IPO, begins trading on Nasdaq(00:23:00) - Confluent Medical, Part 1(00:26:40) - Interview with James Porter, MD, CMO, Robotic Surgical Technologies & Digital Technologies, Medtronic(00:52:43) - Confluent Medical, Part 2(00:56:22) - Interview with Rajit Kamal, VP and GM, Robotic Surgical Technologies, Medtronic

More episodes of the podcast DeviceTalks Podcast Network